8-K: Universal Health Realty Income Trust Q2 2026 Earnings

Universal Health Realty Income Trust reported increased net income and FFO for the second quarter of 2026, driven by property income and reduced interest expenses.

Summary

• Universal Health Realty Income Trust (UHT) reported net income of $5.9 million, or $0.43 per diluted share, for the second quarter of 2026, an increase from $4.5 million, or $0.32 per diluted share, in the second quarter of 2025.
• Adjusted net income, excluding a $724,000 gain on land sale, was $5.2 million, or $0.37 per diluted share, up from $4.5 million in the prior year's quarter.
• Funds From Operations (FFO) for Q2 2026 were $12.5 million, or $0.90 per diluted share, compared to $11.8 million, or $0.85 per diluted share, in Q2 2025.
• For the first six months of 2026, net income was $10.9 million ($0.79 per diluted share), up from $9.3 million ($0.67 per diluted share) in the same period of 2025.
• Adjusted net income for the first six months of 2026 was $10.2 million ($0.74 per diluted share), an increase from $9.3 million in the prior year.
• FFO for the first six months of 2026 was $24.8 million ($1.79 per diluted share), compared to $23.7 million ($1.71 per diluted share) in the first six months of 2025.
• The Trust declared and paid a second quarter dividend of $0.75 per share.
• In April 2026, the Trust amended its credit agreement, increasing borrowing capacity to $475 million from $425 million, with a maturity date of September 30, 2028.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report, with solid operational improvements and FFO growth, though partially obscured by a one-time land sale gain.

Positives

• Increased net income for the second quarter of 2026 to $5.9 million from $4.5 million in Q2 2025.
• Increased diluted earnings per share for Q2 2026 to $0.43 from $0.32 in Q2 2025.
• Adjusted net income increased by $691,000 ($0.05 per diluted share) in Q2 2026 compared to Q2 2025.
• Funds From Operations (FFO) increased to $12.5 million ($0.90 per diluted share) in Q2 2026 from $11.8 million ($0.85 per diluted share) in Q2 2025.
• Six-month net income increased to $10.9 million ($0.79 per diluted share) from $9.3 million ($0.67 per diluted share) in the comparable 2025 period.
• Six-month FFO increased to $24.8 million ($1.79 per diluted share) from $23.7 million ($1.71 per diluted share) in the comparable 2025 period.
• Reduced interest expense due to a decrease in the average effective borrowing rate.
• Increased borrowing capacity under the credit agreement to $475 million from $425 million.

Negatives

• Reported net income for Q2 2026 included a $724,000 gain on the sale of land, which boosted the reported figures.
• The increase in adjusted net income was partially offset by an increase in average borrowings outstanding.
• The company's future results could be materially impacted by various factors including potential reductions in federal funding for Medicaid programs, staffing shortages, government regulation, and macroeconomic conditions.

Risks

• Potential significant reductions in federal funding for state Medicaid programs could lead to reduced payments to facility operators.
• Decreases in staffing availability and related increases in wage expenses due to shortages of nurses and clinical staff.
• Impact of government and administrative regulation of the health care industry.
• Declining patient volumes and unfavorable changes in payer mix due to deteriorating macroeconomic conditions, including increased uninsured patients.
• Potential cost increases and disruptions related to supplies and building materials due to changes in foreign trade laws, restrictions, tariffs, or taxes.
• Increased interest rates have substantially increased borrowing costs and may continue to adversely affect access to capital markets.
• The company's strategy could be adversely affected by capital market conditions impacting its ability to raise capital.

Future Outlook

The filing references forward-looking statements based on current management expectations, but notes that numerous factors, including those detailed in SEC filings, could cause actual results to differ materially. Specific risks include potential reductions in federal funding, staffing shortages, regulatory changes, macroeconomic conditions, and interest rate increases.

Management Comments

• The increase in adjusted net income of $691,000, or $.05 per diluted share, during the second quarter of 2026, as compared to the second quarter of 2025, consisted of a net aggregate increase of $422,000, or $.03 per diluted share, resulting from increased income generated at various properties and an increase of $269,000, or $.02 per diluted share, resulting from a decrease in interest expense due to a decrease in our average effective borrowing rate.
• The increase in FFO was due primarily to the increase in adjusted net income during the second quarter of 2026, as compared to the second quarter of 2025.

Industry Context

StockSavvy.ai notes that Universal Health Realty Income Trust's performance in Q2 2026 reflects the ongoing trends in healthcare real estate, where stable income generation from medical facilities is key. The increase in FFO and adjusted net income, despite a land sale gain, indicates operational improvements and benefits from lower interest rates, which is a positive sign in a sector sensitive to financing costs.

Comparison to Industry Standards

• The reported FFO per diluted share of $0.90 for Q2 2026 is a key metric for REITs. While specific industry benchmarks for Q2 2026 are not yet widely published, UHT's FFO growth of approximately 5.9% year-over-year (from $0.85 in Q2 2025) suggests performance in line with or potentially exceeding the average for healthcare REITs, which often aim for low to mid-single-digit FFO growth.
• The gain on sale of land, while boosting reported net income, is a non-recurring item. The focus on adjusted net income and FFO highlights the company's strategy to present core operating performance, a common practice among REITs to provide a clearer view of ongoing profitability.

Related Party Transactions

• Lease revenue from UHS facilities and other revenue from UHS facilities are reported.
• Advisory fees are paid to UHS.
• A ground lease was entered into with a wholly-owned subsidiary of UHS for the Miller Medical Plaza.
• A wholly-owned subsidiary of UHS has executed a 10-year master flex lease agreement for the Miller Medical Plaza.
• A wholly-owned subsidiary of UHS is acting as project manager for the Miller Medical Plaza construction.

Stakeholder Impact

• Shareholders benefit from the declared and paid second quarter dividend of $0.75 per share.
• Tenants may be impacted by the development of new facilities like the Miller Medical Plaza.
• Suppliers and contractors involved in the Miller Medical Plaza construction will see business opportunities.

Next Steps

• Construction of the Miller Medical Plaza is expected to be completed in December 2026.
• The company has the option to extend the maturity date of its credit agreement for two additional six-month periods.

Key Dates

Recommendation

The filing shows steady operational performance with increased FFO and adjusted net income, alongside a dividend payment. However, the reliance on a land sale gain to boost reported net income and the significant forward-looking risks associated with healthcare funding and macroeconomic conditions suggest a 'hold' recommendation, pending further clarity on these external factors.

Keywords

Universal Health Realty Income Trust, UHT, REIT, Healthcare Real Estate, Medical Office Building, FFO, Net Income, Earnings Release